Tradestie Institutional Equity Comparison Engine
NMTC vs SOLV โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
SOLV Overall Edge
SOLV Captures Institutional Edge (4โ0 Pillars ยท 8โ2 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Solventum Corporation (SOLV) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, NMTC trades at N/M Forward P/E with -63.4% operating margin (+16.3% YoY revenue) versus SOLV at 11.2x Forward P/E and 5.9% operating margin (-7.0% YoY). In options structure, NMTC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SOLV sits in CONSOLIDATION (22nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
SOLV
NMTC N/M vs SOLV 11.2x Fwd P/E
Growth & Margin Winner
SOLV
Op Margin -63.4% vs 5.9% ยท YoY +16.3% vs -7.0%
Momentum & Technical Winner
SOLV
1Y +3.5% vs +9.3% ยท 52W Pos 2% vs 70%
Options & Structure Winner
SOLV
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (22nd %ile IV)
NMTC
NASDAQ
NeuroOne Medical Technologies Corporation Common Stock
Surgical & Medical Instruments & Apparatus
$0.65
-3.38% 1D
Market Cap
$6.1M
1M Return
-33.46%
1Y Return
+3.49%
Forward P/E
N/M
Unified AI Score
45.5 / 100
HOLD
Tech 33.0
Fund 51.0
Flow 60.0
Mom 64.0
SOLV
NYSE
Solventum Corporation
Surgical & Medical Instruments & Apparatus
$84.50
-1.52% 1D
Market Cap
$14.6B
1M Return
-3.37%
1Y Return
+9.3%
Forward P/E
11.2x
Unified AI Score
41.4 / 100
SELL
Tech 25.0
Fund 47.0
Flow 69.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
NMTC +3.49%
SOLV +9.3%
Spread: +5.81 pp (SOLV Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | NMTC Revenue | SOLV Revenue | NMTC Op. Margin | SOLV Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2012 | $0M | N/A | -1491.1% | N/A | NMTC |
| FY2013 | $0M | N/A | -2009.0% | N/A | NMTC |
| FY2014 | $0M | N/A | -4646.1% | N/A | NMTC |
| FY2021 | $0M | N/A | -5735.9% | N/A | NMTC |
| FY2022 | $0M | $8.13B | -5860.2% | 20.8% | SOLV |
| FY2023 | $0M | $8.20B | -612.3% | 20.6% | SOLV |
| FY2024 | $0M | $8.25B | -344.3% | 12.6% | SOLV |
| FY2025 | $10M | $8.32B | -46.5% | 26.2% | SOLV |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | NMTC | SOLV | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $6.1M | $14.6B | Larger Scale | SOLV |
| Trailing P/E Ratio Valuation | N/M | 96.4x | Lower Multiple | SOLV |
| Forward P/E Ratio Valuation | N/M | 11.2x | Lower Multiple | SOLV |
| Revenue Growth (YoY) Growth | +16.3% | -7.0% | Higher Growth | NMTC |
| Operating Margin (TTM) Profitability | -63.4% | 5.9% | Higher Margin | SOLV |
| Net Profit Margin Profitability | -59.7% | 1.9% | Higher Margin | SOLV |
| Return on Equity (ROE) Capital Efficiency | -124.7% | 3.2% | Higher ROE | SOLV |
| 52-Week Range Position Momentum | 2% ($1โ$5) | 70% ($62โ$94) | Stronger Trend | SOLV |
| Beta / 30D Volatility Risk Regime | 1.55ฮฒ ยท 105% Vol | 0.51ฮฒ ยท 36% Vol | Lower Realized Risk | SOLV |
| Unified Institutional Score Composite Signal | 45.5 / 100 (HOLD) | 41.4 / 100 (SELL) | Higher Composite | NMTC |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full NMTC vs SOLV Buy Guide
NMTC
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
SOLV
CONSOLIDATION
115d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
22nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither NMTC nor SOLV registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.